⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Amy ShultzMD

Rheumatology · Duncan, OK 73533

NPI: 1063462430

Share:

33

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersElevated cost per beneficiaryHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

5,283

Total Claims

$2.9M

Drug Cost

370

Beneficiaries

$7,836

Cost/Patient

Risk Score Breakdown 33/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

+596%

Opioid rate vs peers

28.3% vs 4.1% avg

+30%

Cost per patient vs peers

$7,836 vs $6,039 avg

+36%

Brand preference vs peers

10.3% vs 7.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 596% above the average for Rheumatology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

28.3%

Opioid Rate

1,493

Opioid Claims

$111K

Opioid Cost

22.3%

Long-Acting Rate

This provider's opioid prescribing rate of 28.3% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

90% generic

Brand: 544 claims · $2.7M

Generic: 4,725 claims · $169K

Patient Profile

71

Avg Age

81%

Female

1.45

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About